| Hepatitis C virus infection in patients with non‐Hodgkin's lymphoma C Ferri, F Caracciolo, AL Zignego, LL Civita, M Monti, G Longombardo, ... British journal of haematology 88 (2), 392-394, 1994 | 583 | 1994 |
| Preference for subcutaneous or intravenous administration of rituximab among patients with untreated CD20+ diffuse large B-cell lymphoma or follicular lymphoma: results from a … M Rummel, TM Kim, F Aversa, W Brugger, E Capochiani, C Plenteda, ... Annals of Oncology 28 (4), 836-842, 2017 | 138 | 2017 |
| Impact of a new dosing regimen of epoetin alfa on quality of life and anemia in patients with low-risk myelodysplastic syndrome MAA Spiriti, R Latagliata, P Niscola, A Cortelezzi, M Francesconi, ... Annals of Hematology 84, 167-176, 2005 | 120 | 2005 |
| Interferon-α in the idiopathic hypereosinophilic syndrome: consideration of five cases S Ceretelli, E Capochiani, M Petrini Annals of hematology 77, 161-164, 1998 | 59 | 1998 |
| Ruxolitinib rapidly reduces acute respiratory distress syndrome in COVID-19 disease. Analysis of data collection from RESPIRE protocol E Capochiani, B Frediani, G Iervasi, A Paolicchi, S Sani, P Roncucci, ... Frontiers in medicine 7, 466, 2020 | 55 | 2020 |
| The Janus kinase 1/2 inhibitor ruxolitinib in COVID-19 A Gozzetti, E Capochiani, M Bocchia Leukemia 34 (10), 2815-2816, 2020 | 29 | 2020 |
| Paraneoplastic choreic syndrome during non‐Hodgkin's lymphoma A Nuti, R Ceravolo, S Salvetti, G Gambaccini, U Bonuccelli, E Capochiani Movement Disorders: Official Journal of the Movement Disorder Society 15 (2 …, 2000 | 28 | 2000 |
| Real‐world experience with decitabine as a first‐line treatment in 306 elderly acute myeloid leukaemia patients unfit for intensive chemotherapy M Bocchia, A Candoni, E Borlenghi, M Defina, C Filì, C Cattaneo, ... Hematological Oncology 37 (4), 447-455, 2019 | 27 | 2019 |
| Recombinant α2a interferon and polycythemia vera: Clinical results and biological evaluation by means of Fourier‐transform infrared microspectroscopy F Papineschi, A Bucalossi, E Capochiani, E Benedetti, E Bramanti, ... European journal of haematology 53 (4), 213-217, 1994 | 22 | 1994 |
| Motility of rhG‐CSF‐induced neutrophils in patients undergoing chemotherapy: evidence for inhibition detected by image analysis A Azzarà, G Carulli, A Rizzuti‐Gullaci, S Minnucci, E Capochiani, ... British journal of haematology 92 (1), 161-168, 1996 | 21 | 1996 |
| Recovering from chronic myeloid leukemia: the patients’ perspective seen through the lens of narrative medicine G Graffigna, I Cecchini, M Breccia, E Capochiani, R Della Seta, ... Quality of Life Research 26, 2739-2754, 2017 | 20 | 2017 |
| Preference for rituximab subcutaneous (SC) and intravenous (IV) among patients with CD20+ non-Hodgkin's lymphoma (NHL) completing the RASQ measure in randomized phase III … S Rule, J Briones, R Smith, OC Theodore, CA Ngoh, S Osborne, ... Value in Health 17 (7), A537, 2014 | 16 | 2014 |
| Personal history and quality of life in chronic myeloid leukemia patients: a cross-sectional study using narrative medicine and quantitative analysis M Breccia, G Graffigna, S Galimberti, A Iurlo, E Pungolino, M Pizzuti, ... Supportive Care in Cancer 24, 4487-4493, 2016 | 15 | 2016 |
| Lenograstim and filgrastim effects on neutrophil motility in patients undergoing chemotherapy: Evaluation by computer‐assisted image analysis A Azzarà, G Carulli, A Rizzuti‐Gullaci, E Capochiani, M Petrini American Journal of Hematology 66 (4), 306-307, 2001 | 15 | 2001 |
| Third generation chemotherapy with P-VABEC for aggressive non-Hodgkin's lymphomas of the elderly F Caracciolo, M Petrini, E Capochiani, F Papineschi, B Grassi Leukemia & Lymphoma 11 (1-2), 115-118, 1993 | 14 | 1993 |
| A new effective treatment for indolent lymphoma: a pilot study with fludarabine, idarubicin and prednisone combination (FLIDA) F Caracciolo, E Capochiani, F Papineschi, M Petrini Hematological oncology 15 (1), 27-31, 1997 | 10 | 1997 |
| Consolidation therapy with idarubicin, cisplatin and prednisone (CIP) after P-VABEC regimen in the treatment of intermediate and high grade non-Hodgkin's lymphoma of the elderly F Caracciolo, E Capochiani, F Papineschi, M Petrini Leukemia & lymphoma 24 (3-4), 355-361, 1997 | 10 | 1997 |
| Alternating chemotherapy regimen (P‐VABEC) for intermediate and high‐grade non‐Hodgkin's lymphoma of the middle aged and elderly F Caracciolo, M Petrini, E Capochiani, F Papineschi, G Carulli, B Grassi Hematological oncology 12 (4), 185-192, 1994 | 10 | 1994 |
| PrefMab: Final analysis of patient satisfaction with subcutaneous versus intravenous rituximab in previously untreated CD20+ diffuse large B-cell lymphoma or follicular lymphoma M Rummel, TM Kim, C Plenteda, E Capochiani, M Mendoza, R Smith, ... Value in Health 18 (7), A469, 2015 | 9 | 2015 |
| Glutathione-S-transferase activity and multidrug resistance phenotype in chronic lymphocytic leukemia: do they have any clinical relevance? D Di Simone, R Testi, F Caracciolo, E Capochiani, F Ambrogi, B Grassi, ... Haematologica 80 (2), 103-107, 1995 | 9 | 1995 |
